RKVTF (RKVTF) 주가

RKVTF(RKVTF)는 PINK에 상장된 Healthcare · N/A 기업입니다. 현재가 $0.12 (+0.00%), 시가총액 $3.00M, 52주 범위 $0.08 ~ $0.19.

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems. It develops kt-2000 series, which are patented class of oral, small molecule PARP inhibitors with established in vitro and in vivo proof of concept; kt-3000 series drug candidates, which are bi-functional targeted small molecules designed to inhibit both PARP and histone deacetylase; and kt-4000 series, which are small molecules engineered to induce targeted DNA damage in tumor cells. The company is also involved in the development of kt-5000 series of brain-penetrant dual ATR–mTOR inhibitor drug candidates.

핵심 지표

• 현재가: $0.12 (+0.00%)
• 시가총액: $3.00M
• 52주 최저~최고: $0.08 ~ $0.19
• 섹터: Healthcare
• 산업: N/A
• 거래소: PINK

RKVTF의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

RKVTF 기간별 수익률

• 1개월: -31.67%

일봉 종가 기준 계산값이며 과거 성과는 미래 수익을 보장하지 않습니다.

RKVTF 재무 요약

핵심 재무비율 · 수익성 · 성장성

• 배당수익률: 0.00%

자주 묻는 질문